Skip to main
IRTC
IRTC logo

iRhythm Technologies (IRTC) Stock Forecast & Price Target

iRhythm Technologies (IRTC) Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 46%
Buy 38%
Hold 15%
Sell 0%
Strong Sell 0%

Bulls say

iRhythm Technologies Inc. has demonstrated a positive financial trajectory, with its 2025 revenue guidance increased to $735M-$740M, reflecting a strong year-over-year growth rate of 24.6% at the midpoint. The company's adjusted gross margin also saw an improvement, rising to 71.1%, surpassing consensus expectations and indicating enhanced operational efficiency. Additionally, iRhythm's ongoing expansion in international markets, particularly in Japan and the UK, along with increased revenue estimates driven by a robust core business and innovative product offerings, further solidifies a favorable outlook for the company's financial performance.

Bears say

iRhythm Technologies faces a challenging financial outlook due to projected growth slowing to the low-teens, coupled with persistent net losses and potential operational disruptions. Key risks include the impact of regulatory scrutiny from the Department of Justice and the FDA, fluctuating reimbursement policies, and increasing competition that could limit market share and profitability. Additionally, the company's reliance on physician adoption of its Zio service and the competitive nature of the ambulatory cardiac monitoring market further contribute to concerns regarding its future commercial performance and overall financial stability.

iRhythm Technologies (IRTC) has been analyzed by 13 analysts, with a consensus rating of Buy. 46% of analysts recommend a Strong Buy, 38% recommend Buy, 15% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of iRhythm Technologies and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About iRhythm Technologies (IRTC) Forecast

Analysts have given iRhythm Technologies (IRTC) a Buy based on their latest research and market trends.

According to 13 analysts, iRhythm Technologies (IRTC) has a Buy consensus rating as of Nov 4, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $200.15, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $200.15, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

iRhythm Technologies (IRTC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.